Showing results (51-60 of 413) with videos related to
Sort By:
Pageof 42
Urologic Oncology|July 31, 2004
The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategiesJoseph M Unger, Michael LeBlanc, Ian M Thompson, et al.Urology|July 3, 2003
Metastatic seminoma presenting with pulmonary embolus, inferior vena caval thrombosis, and gastrointestinal bleedingJeffrey A Leslie, Lloyd Stegemann, Alexander R Miller, et al.American Family Physician|January 20, 2010
Noninfectious penile lesionsJoel M H Teichman, Jason Sea, Ian M Thompson, et al.Urology|July 28, 2007
Urologists' attitudes regarding cancer clinical researchGregory P Swanson, William R Carpenter, Ian M Thompson, et al.The Journal of Urology|February 1, 2015
The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer LandscapeAndreas N Strobl, Ian M Thompson, Andrew J Vickers, et al.Expert Opinion on Pharmacotherapy|April 26, 2006
Chemoprevention of prostate cancer with finasterideEdith D Canby-Hagino, Timothy C Brand, Javier Hernandez, et al.European Urology Focus|July 21, 2017
Smoking and Prostate Cancer: A Systematic ReviewCosimo De Nunzio, Gerald L Andriole, Ian M Thompson, et al.The Journal of Urology|January 10, 2004
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trialsCatherine M Tangen, Phyllis J Goodman, John J Crowley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Phase III prostate cancer prevention trials: are the costs justified?Ian M Thompson, Catherine M Tangen, Eric A Klein, et al.Urology|December 12, 2002
Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study populationMichael Sebesta, R Duane Cespedes, Eva Luhman, et al.Pageof 42